PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town

By afschroeder • September 25, 2025

Pike C, Rousseau E, Macdonald P, Mapukata P, Lebelo K, Joseph-Davey D, Little F, Bekker LG. PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town. BMC Public Health. 2025 Sep 24;25(1):3109. doi: 10.1186/s12889-025-24370-z. PMID: 40993613.

Tags: Adolescents and young people, HIV prevention, Infectious Diseases, Injectable PrEP, PrEP choice, Publications, south africa

Related Posts

An audit of the HIV drug resistance testing program in Malawi

Kanise H, Nyirenda K, Bisani P, Matola BW, Makwaya A, Simon K, Cox C, Hosseinipour MC, Kanyama C, Worku A, Phiri S, Hoffman RM, Nyirenda[...]

Blood pressure trajectories among people with and without HIV in a US-based prospective cohort study

Sadinski LM, Edwards JK, Herce ME, Avery CL, Miller WC, Simpson RJ Jr, Ramirez C, Palella FJ, Brown TT, Detels R, Magnani JW, Levitan EB,[...]

A taxon-specific measurement of disruption in a multi-modal study of microbiomes and metabolomes reveals system-wide dysbiosis preceding HIV-1 infection

Fouladi F, Chen Y, Bera S, Jarmusch AK, Van Tyne D, Palella FJ, Margolick JB, Chew KW, Sun J, Martinson J, Rinaldo CR, Peddada SD.[...]